Acute Pain Clinical Trial
Official title:
Effect of Low Power Laser in Pain Modulation During Irreversible Inflammation of Tooth Pulp
Verified date | April 2015 |
Source | University of Sao Paulo |
Contact | n/a |
Is FDA regulated | No |
Health authority | Brazil: Ethics Committee |
Study type | Interventional |
Anxiety, pain and discomfort are common stressful situations that occur during the dentistry
practice, especially in the urgency endodontic practice. Studies have concluded that low
intensity laser therapy is effective in treating pain. However, most studies have reported
the low intensity laser therapy in chronic pain, few studies have shown its application on
acute pain and none have evaluated the low intensity laser´s analgesic effect in acute pain
of the pulp inflammation. Since the pulp tissue has the peculiar characteristic to be
surrounded by dentin, in acute pulpits, the inflammatory reaction is more complicated than
usual. Furthermore, during the inflammatory process, sometimes anesthesia is not always
completely effective. Thus, this present study aims to evaluate whether previous therapy
with low intensity laser could, by its analgesic effect, promote greater comfort especially
to this type of patient. 60 patients with acute pulpits pain will be selected to this study
(randomized and double-blinded) and they will be divided in 4 groups:
Group 1 ( n=15) - Control Group; Group 2 (n=15) - Laser 1: 780 nanometers (nm); 40
milliwatts (mW); 4 seconds per point; 0.16 Joules/point; total irradiated points: 02; Group
3 (n=15) - Laser 2: 780nm; 40 mW; 40 seconds per point; 1.6 Joules/point, total irradiated
points: 02; Group 4 (n=15) - Placebo group - Sham Laser Irradiation.
The pain will be evaluated by a visual analogue scale (VAS) in 3 different times: initial
pain, pain immediately after and 15 minutes after interventions (laser irradiation, or sham
laser irradiation). After that, patients with acute pulp irreversible inflammation will be
submitted to conventional endodontic urgency treatment. Data concerning the need of
complimentary local anesthesia will be also taken into account. Data of different groups and
times will be statistically compared.
Status | Completed |
Enrollment | 60 |
Est. completion date | October 2014 |
Est. primary completion date | June 2014 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Patients with acute pain due to irreversible inflammation of the a vital pulp tooth Exclusion Criteria: - Non-Intact Pulp chamber - Necrotic pulp |
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject)
Country | Name | City | State |
---|---|---|---|
Brazil | School of Dentistry - University of São Paulo | São Paulo |
Lead Sponsor | Collaborator |
---|---|
University of Sao Paulo | Fundação de Amparo à Pesquisa do Estado de São Paulo |
Brazil,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Tooth pain modulation during irreversible pulp inflammation after low power laser irradiation | Pain will be measured through VAS (Visual Analog Scale). | Immediately after low power laser irradiation and 15 minutes after low power laser irradiation | Yes |
Secondary | Need of anesthetic supplementation during urgency endodontic treatment | 15 minutes after low power laser irradiation, patients will be submitted to endodontic urgency treatment adopted in School of Dentistry of University of São Paulo. The need of local anesthetic supplementation will be observed between the patients | 15 minutes | Yes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04484610 -
Appropriate Opioid Quantities for Acute Pain - Pharmacist Study
|
Phase 4 | |
Recruiting |
NCT05054179 -
Pecto-Intercostal Fascial Plane Block Catheter Trial for Reduction of Sternal Pain
|
Phase 2/Phase 3 | |
Completed |
NCT04548635 -
VR for Burn Dressing Changes at Home
|
Phase 2/Phase 3 | |
Recruiting |
NCT05370404 -
Prescribing vs. Recommending Over-The-Counter (PROTECT) Analgesics for Patients With Postoperative Pain:
|
N/A | |
Completed |
NCT06054945 -
Clinical Impact of IPACK Block Addition to Suprainguinal Fascia Iliaca Block
|
||
Completed |
NCT03825549 -
A Randomized Trial of Behavioral Economic Approaches to Reduce Unnecessary Opioid Prescribing
|
N/A | |
Completed |
NCT05995912 -
Efficacy and Safety of Etoricoxib-tramadol Tablet in Acute Postoperative Pain
|
Phase 2 | |
Recruiting |
NCT05589246 -
Regional Analgesia in Combination With Cryoanalgesia to Prevent Acute Pain Following Nuss Procedure
|
N/A | |
Recruiting |
NCT05572190 -
Evaluate the Safety and Pharmacokinetic Profile of ETR028 and ETR029 in Healthy Adult Subjects
|
Phase 1 | |
Terminated |
NCT04716413 -
Evaluating the Use of Sublingual Sufentanil in Patients With Suboxone Treatment
|
Phase 4 | |
Active, not recruiting |
NCT03537573 -
Provider-Targeted Behavioral Interventions to Prevent Unsafe Opioid Prescribing for Acute Pain in Primary Care
|
N/A | |
Not yet recruiting |
NCT06317844 -
Examination of Psychological and Physiological Pathways Linking Gratitude and Pain
|
N/A | |
Withdrawn |
NCT02957097 -
Gabapentin as a Pre-emptive Analgesic in Oral and Maxillofacial Surgical Procedures
|
Phase 4 | |
Terminated |
NCT02599870 -
Clinical Study to Evaluate Clinical Impact of PGx-Guided Treatment for Patients Undergoing Elective Spinal Surgical Procedures
|
N/A | |
Completed |
NCT02565342 -
Interscalene Brachial Plexus Block to Treat Pain After Clavicular Surgery
|
Phase 4 | |
Completed |
NCT02984098 -
40% Orally Administered Dextrose Gel is More Effective Than 25% Dextrose
|
Phase 4 | |
Completed |
NCT02380989 -
Integrative Ayurveda Healing Relieves Minor Sports Injury Pain
|
Phase 2 | |
Completed |
NCT02489630 -
Low Dose Ketamine as an Adjunct to Opiates for Acute Pain in the Emergency Department
|
Phase 4 | |
Completed |
NCT03107338 -
Preventive Treatment of Pain After Dental Implant Surgery
|
Phase 4 | |
Completed |
NCT02817477 -
Intranasal Ketamine for Acute Traumatic Pain
|
Phase 4 |